Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
me too but i reckoned someone wants to buy the company
Chart didn't look good but today's jump has prompted me to buy back the share I had sold around £17.
One of the best performing shares on what has been a tumultuous couple of the days on the market. This is starting to look good to me as a recovery play. I am guessing the high Darwazah family ownership and dollar earnings maybe helping support the price in this turbulent market.
You'd hope so, but I've no idea. To quote a great man, markets can stay irrational longer than you can stay solvent.
It's just been down down down for months without nay really bad news to drive the fall.
Anyone else think a bottom is forming here at 1180? It's held up well over the last week. Any technical analysis experts out there?
Fundamentally it looks cheap but shares can overshoot and undershoot in a big way.
I hope we dont see 8.50. My belief of a defensive sector, a PE of around 8 and a historically growing dividend now around 4%, how much cheaper can this really go?
Downward momentum is too strong. I would not be surprised if it goes down to c.850p (last support level in 2018). So, wait and watch for me at present.
I’m watching and waiting for reasons musclehead mentioned below, also likely to leave ftse100 adding to downward pressure. Could be a good recovery play but don’t see any need to rush in.
I'm very tempted at these levels, regardless of falling earnings and unclear outlook, I think the business is intrinsically undervalued below £14
We have ZERO revenue growth - a 9% shrinkage in real, inflation adjusted money terms. The one revenue growth area is injectables - which at 9% barely matched inflation, with negative growth in generics which have intense competition. Maybe its going to be a little better in 23 - doesn't sound like a lot better though. The trouble is the underlying signs aren't good - many of the key players have WALKED recently - both the CHAIR of remuneration and CEO. Is that because they are not seeing good things combined with the recent acquisitions? They seem to have a dire lack of pricing power with a dramatic collapse in profits. If the one cylinder still firing (only to match inflation) - injectables come under similar competition the SP will decline very dramatically.
Got too cheap on a single digit PE
I bought in yesterday at c.£17 yesterday so pleased to see the rally today especially after falling this morning.
A long term hold for the pension pot.
Ah, I see now. I feel it may have found some grounding between £1650/1700 - but today in NY and then Monday with perhaps more clarity on the direction of the war may improve the clarity. I'm in no particular hurry, but have favoured building my Hikma holding for the longer term.
^ £14?
Yes , In for a top up at £14.00. Currently sp only going one way !
I was tempted a few times, but when NY started to look shaky, I decided to 'keep my powder dry'. Tomorrow will be interesting, as will 'Putin Monday'...
I feel confident this company will grow for many years to come. It has a history of sudden drops but quick recoveries so hope the same today. The fact it’s a delayed new product launch isn’t unusual in this field surely.
I can’t decide if today’s RNS shows management’s incompetence or worse.
Following last weeks RNS updating the market it was somewhat of a surprise to see further guidance today and the subsequent 10% fall in the share price in early trading this morning.
I currently have no position in HIK and was looking to purchase around the £18.50 mark and with today's RNS it is looking more likely one for longer term recovery and one for the pension pot. I will sit on my hands for a few hours and see what the market does today (£16.71 a the time of posting to buy)
Thank you for your replies it helps me understand and start thinking should I put in a bit more?.
Well, I bought in yesterday on the premise that “investors” these days are jittery and feel the need to constantly tweak their p/f’s based on over reaction.
The slight negatives are amplified whilst the positive notes are ignored.
Group revenue up 9%
Core operating profit up 12%
Cash flow up 38%
Net debt x 0.6 EBITD
Core operating margin 35-37%
The share price is in a down ward trend but this is a fantastic recovery play for when Mr Market realises value.
Q1 trading statement issued. It looks unexciting, but the drop seems overdone to me
Does anyone know why Hikma shares are dropping so much today? Thank in anticipation of a reply.
Base Case for 31st Dec 2021 Results eps 137.5p x conservative p/e ratio of 15 = £20.62.
The First Quarter Results tomorrow will include Custopharm acquisition figures, the continuation of the revenue growth run rate of 9% and the impact of the share buyback program which will increase eps.
Could the share price start to reflect all of the above?